Myriad Genetics, Inc. recently announced that it has launched myRisk Hereditary Cancer, a new multi-gene diagnostic test that will provide increased sensitivity by analyzing 25 genes associated with eight major cancers including breast, colorectal, ovarian, endometrial, pancreatic, prostate, gastric and melanoma cancer.
